×
GBCC
Sign in to access presentations and abstracts
Email
Password
Sign In
Forgot password?
Create Account
GBCC
GBCC Information
GBCC Resources
Previous Meetings
Photo Album
Announcement
What's NEW
GBCC 2026
Greetings
Overview
Committee
Venue
Program
Program at a Glance
Scientific Program
Invited Speakers
Special Program
Survivors
Abstracts
Presentation
Abstract Topic
Abstract Book
Registration
Registration Info
Hotel Reservation
Sponsorship
Sponsor Information
Exhibition
Satellite Symposium
General Info
About Seoul, Korea
Arrival Assistance
Transportation
Tourist Information
Visit Korea
Login
Language
日本語
中文
GBCC
GBCC Information
GBCC Resources
Previous Meetings
What's NEW
GBCC 2026
Greetings
Overview
Conference Theme
Committee
Venue
Program
Program at a Glance
Scientific Program
Invited Speakers
Special Program
Survivors
Abstracts
Late-Breaking Abstract
Presentation
Abstract Topic
Abstract Book
Registration
Registration Info
Hotel Reservation
Sponsorship
Sponsor Information
Exhibition
Satellite Symposium
General Info
About Seoul, Korea
Arrival Assistance
Transportation
Tourist Information
Visit Korea
MENU
GBCC
GBCC Information
GBCC Resources
Previous Meetings
Photo Album
Announcement
What's NEW
GBCC 2026
Greetings
Overview
Conference Theme
Committee
Venue
Program
Program at a Glance
Scientific Program
Invited Speakers
Special Program
Survivors
Abstracts
Submission Guideline
Presentation
Abstract Topic
Abstract Book
Registration
Registration Info
Hotel Reservation
Sponsorship
Sponsor Information
Exhibition Information
Satellite Symposium
General Info
About Seoul, Korea
Arrival Assistance
Transportation
Tourist Information
Visit Korea
Quick Links
Register Now
Login
GBCC Resources
日本語
中文
Platinum
Satellite Symposium 1
Breakthroughs in Treatment of HER2 Expressing Metastatic Breast Cancer
DATE
April 17 (Thu.)
VENUE
Room 1 (Vista 1+2)
TIME
13:00-13:45
MODERATOR
Ho Yong Park
(Kyungpook National Univ. Chilgok Hospital, Korea)
SPEAKER
Dae-Won Lee
(Seoul National Univ. Hospital, Korea)
Gold (+)
Satellite Symposium 2
First CDK4/6 Inhibitor for HR+/HER2- EBC: Abemaciclib-Increasing the Chance for Cure
DATE
April 17 (Thu.)
VENUE
Room 2 (Grand 1)
TIME
13:00-13:45
MODERATOR
Joohyuk Sohn
(Yonsei Univ. College of Medicine, Korea)
SPEAKER
Matteo Lambertini
(Univ. of Genova - IRCCS Policlinico San Martino Hospital, Italy)
Gold
Satellite Symposium 3
Transforming HR+/HER2- Breast Cancer Care with Ribociclib: A Clinical Perspective
DATE
April 18 (Fri.)
VENUE
Room 1 (Vista 1+2)
TIME
08:00-08:45
MODERATOR
Hyeong-Gon Moon
(Seoul National Univ. Hospital, Korea)
SPEAKER
Sherene Loi
(Peter MacCallum Cancer Centre, Australia)
Platinum
Satellite Symposium 4
Pembrolizumab: Writing a New Chapter in eTNBC
DATE
April 18 (Fri.)
VENUE
Room 1 (Vista 1+2)
TIME
13:00-13:45
MODERATOR
Jin-Hee Ahn
(ASAN Medical Center, Korea)
SPEAKER
Jieun Lee
(The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
Platinum
Satellite Symposium 5
Time is Treatment: How PHESGO is Reshaping the HER2+ Breast Cancer Care
DATE
April 18 (Fri.)
VENUE
Room 2 (Grand 1)
TIME
13:00-13:45
MODERATOR
Min-Ho Park
(Chonnam National Univ. Hwasun Hospital, Korea)
SPEAKER
Jee Hung Kim
(Gangnam Severance Hospital, Korea)
Silver
Satellite Symposium 6
Palbociclib in the Evolving Landscape of HR+ mBC Treatment : Real-World Data and Future Directions
DATE
April 19 (Sat.)
VENUE
Room 1 (Vista 1+2)
TIME
08:00-08:45
MODERATOR
Nam-Sun Paik
(Pohang SM Christianity Hospital, Korea)
SPEAKER
Hee Kyung Ahn
(Samsung Medical Center, Korea)